Loading company…
Rubicon Research makes specialty pharmaceuticals and drug-device combination products, mainly for regulated markets such as the US.
Founded in 2000 and headquartered in Mumbai, India, Rubicon Research Pvt. Ltd. develops pharmaceutical formulations, including oral capsules, tablets, syrups and ophthalmic drops, with 55 products commercialized in the US as of March 31, 2024. Revenue in 2023 was INR 49,031,941.50. General Atlantic acquired a 70% stake from Everstone Capital Partners in April 2019 for INR 10 billion, a Secondary Buyout.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in